Company: TXG
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001770787-25-000051
Chunk: 51

Company: 10x Genomics, Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 8
Chunk 51
---
24$%InstrumentsChromium$5,727 $8,792 $(3,065)(35)%$11,640 $16,642 $(5,002)(30)%Spatial8,770 15,060 (6,290)(42)17,672 32,663 (14,991)(46)Total instruments revenue14,497 23,852 (9,355)(39)29,312 49,305 (19,993)(41)ConsumablesChromium85,788 94,108 (8,320)(9)169,897 178,035 (8,138)(5)Spatial36,397 29,254 7,143 24 67,644 55,662 11,982 22 Total consumables revenue122,185 123,362 (1,177)(1)237,541 233,697 3,844 2 Services8,475 5,776 2,699 47 16,127 10,993 5,134 47 Products and services revenue145,157 152,990 (7,833)(5)282,980 293,995 (11,015)(4)License and royalty revenue27,751 114 27,637 NM44,811 115 44,696 NMTotal revenue$172,908 $153,104 $19,804 13 %$327,791 $294,110 $33,681 11 %

Products and services revenue decreased $7.8 million, or 5%, to $145.2 million for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. Instruments revenue decreased $9.4 million, or 39%, to $14.5 million for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. Consumables revenue decreased $1.2 million, or 1%, to $122.2 million for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. Services revenue increased $2.7 million, or 47%, for the three months ended June 30, 2025 as compared to three months ended June 30, 2024, primarily driven